Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2013 / Cilt: 19 - Sayı: 2

Ratlarda gliserol ile indüklenen miyoglobinürik akut böbrek yetmezliği üzerine losartanın etkileri

Effects of losartan on glycerol-induced myoglobinuric acute renal failure in rats

Pages
253–258
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We think that there is no positive effect of losartan on the pathogenesis of mARF.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myoglobinuric acute renal failure (mARF) is an uremic syndrome which develops due to damage of skeletal muscle.
📊
Key Findings & Data:It was demonstrated that free radicals and nitric oxide (NO) play an important role in pathogenesis of mARF.
💡
Conclusion & Impact:We think that there is no positive effect of losartan on the pathogenesis of mARF.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:sodyum · sıçan · arginin

Abstract

Myoglobinuric acute renal failure (mARF) is an uremic syndrome which develops due to damage of skeletal muscle. It was demonstrated that free radicals and nitric oxide (NO) play an important role in pathogenesis of mARF. Our aim was to investigate the effect of losartan, a drug known for its antioxidant effect, on mARF. In our study, a total of 34 male Spraque Dawley rats were divided into four groups. 1st and 2nd groups were injected with saline, 3rd and 4th groups were injected with intramuscular glycerol. One and 24 hours later, 1st and 3rd groups received saline orally and 2nd and 4th groups have taken 10 mg/kg losartan. Urine was collected; the blood samples and kidneys of the rats were taken under the anesthesia. The levels of NO, arginine, asymmetric dimethylarginine (ADMA), glutathione (GSH) and malondialdehyde (MDA) were determined, renal functions and histopathological changes examined. In our study, we found that levels of urea, creatinine, and potassium, in serum samples and MDA and ADMA in renal tissue were increased in 3rd group when it’s compared with the 1st group. Levels of sodium, arginine in serum samples and arginine in renal tissue were reduced 3rd group when compared with the 1st group. When 3rd and 4th groups were compared, serum creatinine was higher in the latter group whereas ADMA level in renal tissue was lower in the same group. We think that there is no positive effect of losartan on the pathogenesis of mARF.

Özet

Miyoglobinürik akut böbrek yetmezliği (mABY) iskelet kaslarının hasarlanmasıyla oluşan üremik bir sendromdur. Nitrik oksit (NO) ve serbest radikallerin mABY patogenezinde önemli rol oynadığı gösterilmiştir. Çalışmamızda antioksidan etkileri olduğu bildirilen losartanın mABY’deki etkilerini araştırmayı amaçladık. Çalışmamızda 4 grupta toplam 34 adet erkek Spraque Dawley sıçan kullanıldı. 1. ve 2. gruba fizyolojik serum, 3. ve 4. gruba gliserol intramüsküler enjekte edildi. 1 ve 24 saat sonra 1. ve 3. gruba distile su, 2. ve 4. gruba 10 mg/kg losartan oral yolla verildi. İdrarları toplandı, anestezi altında kan ve böbrekleri alındı. NO, arginin, asimetrik dimetilarginin (ADMA), glutatyon (GSH), malondialdehit (MDA) düzeyleri, histopatolojik değişiklikler ve böbrek fonksiyonları incelendi. Çalışmamızda 1. grup ile karşılaştırıldığında 3. grupta serumda üre, kreatinin, potasyum, böbrek dokusunda MDA ve ADMA düzeylerinde artma; serum sodyum, arginin, böbrek dokusunda arginin düzeylerinde azalma gözlendi. 3. grup ile karşılaştırıldığında 4. grupta serum kreatinin düzeyinde artış, böbrek dokusunda ADMA düzeyinde azalma saptandı. Bu sonuçlar ışığında losartanın mABY patogenezi üzerinde olumlu etkilerinin olmadığını düşünüyoruz.

🔖

Cite This Article

KAYA, O., AYDOĞDU, N., TAŞTEKİN, E., KARADAĞ, Ç. H., GÜNDÜZ, Ö., SÜT, N. (2013). Ratlarda gliserol ile indüklenen miyoglobinürik akut böbrek yetmezliği üzerine losartanın etkileri. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 19 - Sayı: 2, 253–258. https://ajindex.com/articles/272825

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Sever L: Ezilme sendromu. Türk Ped Arşivi, 44, 43-47, 2009
  2. Bosch X, Poch E, Grau JM: Rhabdomyolysis and Acute Kidney Injury. N Engl J Med, 361 (1): 62-72, 2009
  3. Boutaud O, Roberts LJ: Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure. Free Radic Biol Med, 51 (5): 1062-1067, 2011
  4. Aydogdu N, Atmaca G, Yalcin O, Taskiran R, Tastekin E, Kaymak K: Protective effects of L-Carnitine on myoglobinuric acute renal failure in rats. Clin Exp Pharmacol, 33, 119-124, 2006
  5. Atakişi O, Atakişi E, Atabay T, Uzun M: L-Arjinin ve N ω -Nitro-L-Arjinin Metil Esteri uygulamasının beyin, karaciğer, böbrek dokusu nitrik oksit ve malondialdehit düzeylerine etkisi. Kafkas Univ Vet Fak Derg, 15 (1): 71-75, 2009
  6. Milsom AB, Patel NS, Mazzon E, Tripatara P, Storey A, Mota-Flipe A, Sepodes B, Webb AJ, Cuzzocrea S, Hobbs AJ, Thiemermann C, Ahluwalia A: Role for endothelial nitric oxide synthase in nitrite-induced protection against renal ischemia-reperfusion injury in mice. Nitric Oxide, 22 (2): 141-148, 2010
  7. Sun D, Wang Y, Liu C, Zhou X, Xiao A: Effects of nitric oxide on renal interstitial fibrosis in rats with unilateral ureteral obstruction. Life Sci, 90 (23-24): 900-909, 2012
  8. Sun J, Shannon M, Ando Y, Schnackenberg LK, Khan NA, Portilla D, Beger RD: Serum metabolomic profiles from patients with acute kidney injury: A pilot study. J Chromatogr B, 15 (893-894): 107-113, 2012
  9. Pope AJ, Karuppiah K, Cardounel AJ: Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pharmacol Res, 60 (6): 461-465, 2009
  10. Vanholder R, Sever MS, Erek E, Lameire N: Rhabdomyolysis. J Am Soc Nephrol, 11(8): 1553-1561, 2000
  11. Vallance P, Leiper J: Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vas Biol, 24 (6): 1023-1030, 2004
  12. Xu F, Mao C, Liuu Y, Wu L, Xu Z, Zhang L: Losartan chemistry and its effects via AT-1 mechanisms in the kidney. Curr Med Chem, 16 (28): 3701-3715, 2009
  13. Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T: Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxid release. Hypertension, 40 (4): 521-527, 2002
  14. Kamper M, Tsimpoukidi O, Chatzigeorgiou A, Lymberi M, Kamper EF: The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats. Transl Res, 156 (1): 26-36, 2010
  15. Lafayette RA, Mayer G, Park SK,